Mirae Asset Global Investments Co., Ltd. Astrazeneca PLC Transaction History
Mirae Asset Global Investments Co., Ltd.
- $22.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Astrazeneca PLC stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 297,576 shares of AZN stock, worth $19.3 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
297,576
Previous 179,217
66.04%
Holding current value
$19.3 Million
Previous $14 Million
65.89%
% of portfolio
0.1%
Previous 0.07%
Shares
30 transactions
Others Institutions Holding AZN
# of Institutions
1,347Shares Held
491MCall Options Held
5MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD64.9MShares$4.2 Billion0.61% of portfolio
-
Primecap Management CO Pasadena, CA42.6MShares$2.76 Billion2.44% of portfolio
-
Wellington Management Group LLP Boston, MA40.6MShares$2.62 Billion0.58% of portfolio
-
Capital International Investors Los Angeles, CA36.7MShares$2.37 Billion0.6% of portfolio
-
Franklin Resources Inc San Mateo, CA17.6MShares$1.14 Billion0.44% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $200B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...